Manifold Bio

Lead, Implementation Engineering

Boston, Massachusetts, United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, ResearchIndustries

Requirements

The Lead, Implementation Data Engineering role requires expert-level data engineering and ETL capabilities, deep knowledge of healthcare standards (HL7, FHIR, DICOM, OMOP), advanced data modeling expertise, Python and SQL proficiency, proven experience with AWS or GCP, strong background in data security and compliance, and demonstrated team leadership abilities. Candidates should have extensive hands-on experience working with biomedical data and thrive on the unique challenges and complexities that come with handling genomic, clinical, and research datasets.

Responsibilities

As the Lead, Implementation Data Engineering, you will lead platform implementations to integrate diverse biomedical data sources, transform complex datasets into standardized, research-ready formats, optimize implementation processes while growing a high-performing team, and design scalable data engineering solutions using Manifold’s platform. You will also work hands-on with clients and mentor your team, ensuring successful project delivery and contributing to the overall success of Manifold’s Trusted Research Environment (TRE).

Skills

Data Management
Genomic Data
Imaging Data
Biomedical Data
Data Integration
Research Infrastructure
Scientific Collaboration

Manifold Bio

Designs precision biologics using in vivo methods

About Manifold Bio

Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Boston, MassachusettsHeadquarters
2020Year Founded
$58.8MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Risks

Increased competition from companies like Insamo and Infinimmune.
Rapid AI and ML advancements may outpace Manifold Bio's current technology.
Regulatory challenges in in vivo testing could delay product development timelines.

Differentiation

Manifold Bio uses proprietary mCodes™ technology for protein multiplexing in drug design.
Their in vivo drug design platform is the first of its kind globally.
The company specializes in precision biologics, focusing on complex biologics development.

Upsides

Raised $40M in Series A funding, indicating strong market interest.
Their platform could revolutionize in vivo testing by testing multiple molecules simultaneously.
Strategic partnerships with multiple investors enhance growth and development opportunities.

Land your dream remote job 3x faster with AI